On August 16, 2022, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr).On July 18, 2022, the New York State Department of Health (NYSDOH) notified CDC of detection of poliovirus type 2 in stool specimens from an unvaccinated immunocompetent young adult from Rockland County, New York, who was experiencing acute flaccid weakness. The patient initially experienced fever, neck stiffness, gastrointestinal symptoms, and limb weakness. The patient was hospitalized with possible acute flaccid myelitis (AFM). Vaccine-derived poliovirus type 2 (VDPV2) was detected in stool specimens obtained on days 11 and 12 after initial symptom onset. To date, related Sabin-like type 2 polioviruses have been detected in wastewater* in the patient's county of residence and in neighboring Orange County up to 25 days before (from samples originally collected for SARS-CoV-2 wastewater monitoring) and 41 days after the patient's symptom onset. The last U.S. case of polio caused by wild poliovirus occurred in 1979, and the World Health Organization Region of the Americas was declared polio-free in 1994. This report describes the second identification of community transmission of poliovirus in the United States since 1979; the previous instance, in 2005, was a type 1 VDPV (1). The occurrence of this case, combined with the identification of poliovirus in wastewater in neighboring Orange County, underscores the importance of maintaining high vaccination coverage to prevent paralytic polio in persons of all ages.
Running title: Norovirus diarrhoea in children in BrazilWord count: Abstract: 199. Manuscript: 2255.
Highlights Gastroenteritis is one of the most important causes of morbidity and mortality in children. Noroviruses are a leading cause of sporadic cases and outbreaks of acute gastroenteritis. Norovirus annual detection rates increased over the study period. The detection of norovirus was higher among young children.
AbstractBackground: Gastroenteritis is one of the most important causes of morbidity and mortality
BackgroundIn view of the high mortality for cardiovascular diseases, it has become
necessary to stratify the main risk factors and to choose the correct
diagnostic modality. Studies have demonstrated that a zero calcium score
(CS) is characteristic of a low risk for cardiovascular events. However, the
prevalence of individuals with coronary atherosclerotic plaques and zero CS
is conflicting in the specialized literature.ObjectiveTo evaluate the frequency of patients with coronary atherosclerotic plaques,
their degree of obstruction and associated factors in patients with zero CS
and indication for coronary computed tomography angiography (CCTA).MethodsThis is a cross-sectional, prospective study with 367 volunteers with zero CS
at CCTA in four diagnostic imaging centers in the period from 2011 to 2016.
A significance level of 5% and 95% confidence interval were adopted.ResultsThe frequency of atherosclerotic plaque in the coronary arteries in 367
patients with zero CS was 9.3% (34 individuals). In this subgroup, mean age
was 52 ± 10 years, 18 (52.9%) were women and 16 (47%) had significant
coronary obstructions (> 50%), with involvement of two or more segments
in 4 (25%) patients. The frequency of non-obese individuals (90.6% vs 73.9%,
p = 0.037) and alcohol drinkers (55.9% vs 34.8%, p = 0.015) was
significantly higher in patients with atherosclerotic plaques, with an odds
ratio of 3.4 for each of this variable.ConclusionsThe frequency of atherosclerotic plaque with zero CS was relatively high,
indicating that the absence of calcification does not exclude the presence
of plaques, many of which obstructive, especially in non-obese subjects and
alcohol drinkers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.